MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with F

Flecainide

Flecainide 50mg tablets

No stability information

Stability notes for Flecainide 50mg tablets

There are no stability notes for this medicine.

Suppliers (11) of Flecainide 50mg tablets
Flecainide 50mg tablets (A A H Pharmaceuticals Ltd)
Flecainide 50mg tablets (AAH Hillcross)
Flecainide 50mg tablets (Accord-UK Ltd)
Flecainide 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Flecainide 50mg tablets (Almus Pharmaceuticals Ltd)
Flecainide 50mg tablets (Brown & Burk UK Ltd)
Flecainide 50mg tablets (Medihealth (Northern) Ltd)
Flecainide 50mg tablets (Milpharm Ltd)
Flecainide 50mg tablets (Phoenix Healthcare Distribution Ltd)
Flecainide 50mg tablets (Sigma Pharmaceuticals Plc)
Flecainide 50mg tablets (Tillomed Laboratories Ltd)

Flecainide 100mg tablets

No stability information

Stability notes for Flecainide 100mg tablets

There are no stability notes for this medicine.

Suppliers (10) of Flecainide 100mg tablets
Flecainide 100mg tablets (A A H Pharmaceuticals Ltd)
Flecainide 100mg tablets (Accord-UK Ltd)
Flecainide 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Flecainide 100mg tablets (Almus Pharmaceuticals Ltd)
Flecainide 100mg tablets (Brown & Burk UK Ltd)
Flecainide 100mg tablets (Medihealth (Northern) Ltd)
Flecainide 100mg tablets (Milpharm Ltd)
Flecainide 100mg tablets (Phoenix Healthcare Distribution Ltd)
Flecainide 100mg tablets (Sigma Pharmaceuticals Plc)
Flecainide 100mg tablets (Tillomed Laboratories Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.